VANCOUVER, British Columbia, Feb. 20, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that Dr. Mark Murray, President and CEO of Tekmira, will provide a corporate overview at the 2014 RBC Capital Markets’ Global Healthcare Conference on Tuesday, February 25, 2014 at 3:05 pm ET at the New York Palace Hotel.
Help employers find you! Check out all the jobs and post your resume.
